Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia is a common hair loss condition influenced by various factors and linked to psychosocial and cardiovascular issues.

People with androgenic alopecia (AGA) have a higher chance of getting metabolic syndrome.

Treatments for enlarged prostate can cause problems with ejaculation, and less invasive options might preserve sexual function better.

Ashwagandha serum improves hair health and quality of life in people with hair loss.

Overweight women with PCOS are more likely to have excess male hormones.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Thai rice bran extracts, especially from Tubtim Chumphae rice, can significantly reduce the activity of hair loss genes, with x-tocopherol showing potential as an anti-hair loss product.

Mice lacking steroid 5α-reductase 2 show less aggression and better impulse control.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

Scientists created cell lines from balding patients and found that cells from the front of the scalp are more affected by hormones that cause hair loss than those from the back.

Dutasteride is more effective than finasteride for hair loss treatment.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.

Sleep, testosterone levels, and a specific enzyme activity affect skin oil production in women.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

Testosterone and dihydrotestosterone treatments can help with penile growth in males with 5α-reductase type 2 deficiency, with dihydrotestosterone being more effective in infancy.

Gene variant linked to prostate cancer, hormone levels, and hair loss.

Androgen treatment with dihydrotestosterone may help maintain height in patients with 5-α-reductase type 2 deficiency, especially before puberty.

5α-reductase-2 deficiency causes ambiguous genitalia at birth and affects male sexual development, but individuals often develop male characteristics at puberty.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

Compound 4 is a promising treatment for hair loss with low toxicity.